MiRNA expression profiling of mycosis fungoides

Molecular Oncology

Volumn 5, Issue 3, 2011, Pages 273-280

  van Kester, Marloes S ^a   Ballabio, Erica ^b   Benner, Marchina F ^a   Chen, Xiao H ^b   Saunders, Nigel J ^c   van der Fits, Leslie ^a   van Doorn, Remco ^a   Vermeer, Maarten H ^a   Willemze, Rein ^a   Tensen, Cornelis P ^a   Lawrie, Charles H ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CTCL; Microarray; MiRNA; Mycosis fungoides

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 92A; MICRORNA 93; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; ECZEMA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MALE; MICROARRAY ANALYSIS; MYCOSIS FUNGOIDES; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA FINGERPRINTING; SKIN BIOPSY;

EID: 79957472046     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2011.02.003     Document Type: Article

References (30)

1. Ballabio E., Mitchell T., van Kester M.S., Taylor S., Dunlop H.M., Chi J., Tosi I., Vermeer M.H., Tramonti D., Saunders N.J., Boultwood J., Wainscoat J.S., Pezzella F., Whittaker S.J., Tensen C.P., Hatton C.S., Lawrie C.H. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 2010, 116:1105-1113.
2. Bonauer A., Dimmeler S. The microRNA-17-92 cluster: still a miRacle?. Cell Cycle 2009, 8:3866-3873.
3. Booken N., Gratchev A., Utikal J., Weiss C., Yu X., Qadoumi M., Schmuth M., Sepp N., Nashan D., Rass K., Tuting T., Assaf C., Dippel E., Stadler R., Klemke C.D., Goerdt S. Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia 2008, 22:393-399.
4. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
5. Calin G.A., Croce C.M. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006, 25:6202-6210.
6. Calin G.A., Croce C.M. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J. Clin. Invest. 2007, 117:2059-2066.
7. Campbell J.J., Clark R.A., Watanabe R., Kupper T.S. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 2010, 116:767-771.
8. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
9. Du L., Schageman J.J., Subauste M.C., Saber B., Hammond S.M., Prudkin L., Wistuba I.I., Ji L., Roth J.A., Minna J.D., Pertsemlidis A. miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol. Cancer Res. 2009, 7:1234-1243.
10. Eis P.S., Tam W., Sun L., Chadburn A., Li Z., Gomez M.F., Lund E., Dahlberg J.E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A 2005, 102:3627-3632.
11. Fang L., Deng Z., Shatseva T., Yang J., Peng C., Du W.W., Yee A.J., Ang L.C., He C., Shan S.W., Yang B.B. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2010.
12. Gambichler T., Bischoff S., Bechara F.G., Altmeyer P., Kreuter A. Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders. J. Dermatol. Sci. 2008, 49:125-132.
13. Kent O.A., Mendell J.T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006, 25:6188-6196.
14. Kim Y.K., Yu J., Han T.S., Park S.Y., Namkoong B., Kim D.H., Hur K., Yoo M.W., Lee H.J., Yang H.K., Kim V.N. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009, 37:1672-1681.
15. Kluiver J., Poppema S., de J.D., Blokzijl T., Harms G., Jacobs S., Kroesen B.J., van den B.A. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 2005, 207:243-249.
16. Laharanne E., Oumouhou N., Bonnet F., Carlotti M., Gentil C., Chevret E., Jouary T., Longy M., Vergier B., Beylot-Barry M., Merlio J.P. Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes. J. Invest. Dermatol. 2010, 130:1707-1718.
17. Lawrie C.H. MicroRNA expression in lymphoma. Expert Opin. Biol. Ther. 2007, 7:1363-1374.
18. Lawrie C.H. MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?. J. Cell Mol. Med. 2008, 12:1432-1444.
19. Li Y., Tan W., Neo T.W., Aung M.O., Wasser S., Lim S.G., Tan T.M. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009, 100:1234-1242.
20. Merkel O., Hamacher F., Laimer D., Sifft E., Trajanoski Z., Scheideler M., Egger G., Hassler M.R., Thallinger C., Schmatz A., Turner S.D., Greil R., Kenner L. Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma. Proc. Natl. Acad. Sci. U S A 2010, 107:16228-16233.
21. O'Connell R.M., Rao D.S., Chaudhuri A.A., Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10:111-122.
22. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de M.I., Iliopoulos D., Pilozzi E., Liu C.G., Negrini M., Cavazzini L., Volinia S., Alder H., Ruco L.P., Baldassarre G., Croce C.M., Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13:272-286.
23. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van D.S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
24. Salgado R., Servitje O., Gallardo F., Vermeer M.H., Ortiz-Romero P.L., Karpova M.B., Zipser M.C., Muniesa C., Garcia-Muret M.P., Estrach T., Salido M., Sanchez-Schmidt J., Herrera M., Romagosa V., Suela J., Ferreira B.I., Cigudosa J.C., Barranco C., Serrano S., Dummer R., Tensen C.P., Sole F., Pujol R.M., Espinet B. Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. J. Invest. Dermatol. 2010, 130:1126-1135.
25. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
26. van Doorn R., Dijkman R., Vermeer M.H., Out-Luiting J.J., van der Raaij-Helmer E.M., Willemze R., Tensen C.P. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res. 2004, 64:5578-5586.
27. van Doorn R., Zoutman W.H., Dijkman R., de Menezes R.X., Commandeur S., Mulder A.A., Van der Velden P.A., Vermeer M.H., Willemze R., Yan P.S., Huang T.H., Tensen C.P. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J. Clin. Oncol. 2005, 23:3886-3896.
28. van Doorn R., van Kester M.S., Dijkman R., Vermeer M.H., Mulder A.A., Szuhai K., Knijnenburg J., Boer J.M., Willemze R., Tensen C.P. Oncogenomic analysis of mycosis fungoides reveals major differences with sezary syndrome. Blood 2009, 113:127-136.
29. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., Ralfkiaer E., Chimenti S., Az-Perez J.L., Duncan L.M., Grange F., Harris N.L., Kempf W., Kerl H., Kurrer M., Knobler R., Pimpinelli N., Sander C., Santucci M., Sterry W., Vermeer M.H., Wechsler J., Whittaker S., Meijer C.J. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105:3768-3785.
30. Zhang J., Jima D.D., Jacobs C., Fischer R., Gottwein E., Huang G., Lugar P.L., Lagoo A.S., Rizzieri D.A., Friedman D.R., Weinberg J.B., Lipsky P.E., Dave S.S. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009, 113:4586-4594.